References
- Cunningham ET Jr. Cytomegalovirus: ophthalmic perspectives on a pervasive pathogen. Expert Rev Ophthalmol. 2011;6:489–491
- Jabs DA. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome–bench to bedside: LXVII Edward Jackson Memorial Lecture. American Journal of Ophthalmology. 2011;151:198e1–216 e1
- Thorne JE, Holbrook JT, Jabs DA, et al. Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology. 2007;114:591–598
- Takakura A, Tessler HH, Goldstein DA, et al. Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature. Ocul Immunol Inflamm. 2014;22:175–182
- Jap A, Chee S-P. Cytomegalovirus-associated anterior segment inflammation. Expert Rev Ophthalmol. 2011;6:517–528
- Jap A, Chee SP. Viral anterior uveitis. Curr Opin Ophthalmol. 2011;22:483–488
- Cunningham ET Jr. The expanding spectrum of viral anterior uveitis. Ophthalmology. 2011;118:1903–1904
- Shah JM, Leo SW, Lee TL, et al. A cytomegalovirus retinitis screening program: evaluation of enrollment criteria for hiv patients in singapore. Ocul Immunol Inflamm. 2015;23:362–370
- Mathur G, Ratra D, Bhuibhar SS, Roy R. Clinical outcomes of retinal detachment surgery following cytomegalovirus retinitis in patients on highly active anti-retroviral therapy for acquired immune deficiency syndrome. Ocul Immunol Inflamm. 2015;23:400–404
- Jeon S, Lee WK. Cytomegalovirus retinitis in a human immunodeficiency virus-negative cohort: long-term management and complications. Ocul Immunol Inflamm. 2015;23:392–399
- Woo JH, Lim WK, Ho SL, Teoh SC. Characteristics of cytomegalovirus uveitis in immunocompetent patients. Ocul Immunol Inflamm. 2015;23:378–383
- Cunningham ET Jr, Acharya N, Kempen JH, Zierhut M. Design and interpretation of clinic-based studies in uveitis. Ocu Immunol Inflamm. 2015; 23:267–270
- Kempen JH, Min YI, Freeman WR, et al. Studies of Ocular Complications of AIDS Research Group. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006;113:684–694
- Agarwal A, Kumari N, Trehan A, et al. Outcome of cytomegalovirus retinitis in immunocompromised patients without human immunodeficiency Virus treated with intravitreal ganciclovir injection. Graefes Arch Clin Exp Ophthalmol. 2014; 252:1393–1401
- Kuo IC, Kempen JH, Dunn JP, et al. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol. 2004; 138:338–436
- Zelefsky JR, Cunningham ET Jr. Evaluation and management of elevated IOP in patients with uveitis. American Academy of Ophthalmology, Focal Points 2010, XXVIII, number 6 (Section 3 of 3)
- Chee SP, Jap A. Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010;94:1648–1652
- Chee SP, Bacsal K, Jap A, et al. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol. 2008; 145:834–840
- Sobolewska B, Deuter C, Doycheva D, Zierhut M. Long-term oral therapy with valganciclovir in patients with Posner-Schlossman syndrome. Graefes Arch Clin Exp Ophthalmol. 2014;252:117–124
- Accorinti M, Gilardi M, Pirraglia MP, et al. Cytomegalovirus anterior uveitis: long-term follow-up of immunocompetent patients. Graefes Arch Clin Exp Ophthalmol. 2014; 252:1817–1824
- Cunningham ET Jr, Baglivo E. Fuchs heterochromic iridocyclitis–syndrome, disease, or both? Am J Ophthalmol. 2009;148:479–481
- Pleyer U, Chee SP. Current aspects on the management of viral uveitis in immunocompetent individuals. Clin Ophthalmol. 2015;9:1017–1028